Since it was discovered that the hazards of hormone therapy outweighed the benefits, scientists have been trying to find a safe, normal way to ease the symptoms of Menopause
Members are currently becoming recruited for the follow-up clinical trial of any treatment known as MF101 produced by Bionovo, Incorporation. In its original clinical trial, MF101 provided women inside the study with preliminary proof of relief from many of these symptoms seeing that hot whizzes and evening sweats, without the risks linked to hormone remedy.
The treatment being tested medically targets just one single of the two known female receptors-the estrogen receptor beta. Laboratory data has shown that MF101 does not cause the proliferation of breast or uterine malignancy cells just how hormone therapy can, making the medication a safer alternative to now available hormone therapies.
In 2002, the Ladies Health Gumption (WHI) Estrogen Plus Progestin Trial, with over sixteen, 000 women of all ages participants, was stopped early when it was found that the standard dose of combo hormone remedy increased the chance of breast cancer, stroke, heart attacks, blood clots and dementia.
“Given the void that exists for a safe and effective treatment for menopausal symptoms, the aim is always to discover and develop fresh drugs including MF101 that will abate a lot of the symptoms which have historically recently been treated with hormones, very well said Doctor Mary Tagliaferri. Tagliaferri is certainly co-author of “The New Menopause Reserve: The Experts Help you create Informed Decisions on HORMONE REPLACEMENT THERAPY, Natural Body hormone Therapy, Natural Therapies, Classic Chinese Medicine And More” (Avery, 2006) and Chief Medical Officer of Bionovo, which can be developing the drug.
The clinical trials will be held at under the directorship of well known researcher Dr . Deborah Grady at 4 leading academic medical centers.
Bionovo expects this Period 2 trial to be accomplished by the second one fourth of 2018.
“If the brand new drug testifies to be effective, we will be providing health care practitioners using a treatment they will comfortably advise to women experiencing perimenopause, ” stated Dr . Tagliaferri.